Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Conditions: Melanoma; Coronary Microvascular Dysfunction; Cardiotoxicity

Sponsors: Abramson Cancer Center at Penn Medicine

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 28, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments